Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients with Advanced Colorectal Polyps

NCT04160832 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT04160832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04160832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients with Advanced Colorectal Polyps
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Completed
Start date
October 24, 2019
Completion date
August 30, 2024
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasm